Marshall Wace North America’s Veracyte VCYT Stock Holding History

Marshall Wace North America’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-37,225	Closed	-$2M	–	1795
2021 Q1	$2M	Buy	+37,225	New	+$2.14M	0.01%	827
2020 Q2	–	Sell	-4,108	Closed	-$100K	–	1504
2020 Q1	$100K	Buy	+4,108	New	+$103K	﹤0.01%	999
2019 Q3	–	Sell	-33,598	Closed	-$958K	–	1569
2019 Q2	$958K	Buy	+33,598	New	+$839K	0.01%	760

Other funds holding VCYT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace North America's VCYT Position: Q2 2021 in Review

Marshall Wace North America sold out of Veracyte (VCYT) in Q2 2021, closing a stake of 37,225 shares — an estimated $2M sold.

Marshall Wace North America first reported a position in VCYT in Q2 2019 and held it in 3 quarters. The position peaked at $2M in Q1 2021. 214 funds tracked by Wall St. Rank hold VCYT as of Q2 2021.

Marshall Wace North America reported no remaining Veracyte position as of Q2 2021 after selling out during the quarter.
Marshall Wace North America sold 37,225 Veracyte shares in Q2 2021, an estimated $2M.
Marshall Wace North America first reported a position in Veracyte in Q2 2019 and held it in 3 quarters.
Marshall Wace North America's Veracyte position peaked at $2M in Q1 2021.
214 funds tracked by Wall St. Rank held Veracyte as of Q2 2021.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.